Compumedics Limited - Income Statement (TTM)

Compumedics Limited
AU ˙ ASX
$0.30 ↓ -0.02 (-4.76%)
2025-09-05
SHARE PRICE
Income Statement (TTM)

Compumedics Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 35 35 35 36 35 34 37 39 40 41 42 43 47 50 50 50 49 47 49 51
Change (%) -0.37 1.34 1.32 -1.78 -1.81 6.00 5.66 3.14 3.05 2.30 2.25 8.40 7.75 0.13 0.13 -2.87 -2.96 3.87 3.73
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 17 17 17 17 17 17 18 18 19 20 20 21 22 23 23 24 23 22 21 20
Change (%) -0.99 -0.44 -0.44 0.44 0.44 5.12 4.87 3.86 3.72 2.41 2.36 5.36 5.09 1.30 1.28 -2.53 -2.60 -5.34 -5.64
% of Revenue 48.34 48.05 47.21 46.39 47.43 48.52 48.12 47.75 48.09 48.40 48.45 48.50 47.14 45.98 46.52 47.06 47.22 47.39 43.19 39.29
Gross Operating Profit 18 18 19 19 18 18 19 20 21 21 22 22 25 27 27 27 26 25 28 31
Change (%) 0.20 2.98 2.90 -3.70 -3.84 6.83 6.40 2.48 2.42 2.20 2.16 11.26 10.12 -0.87 -0.88 -3.17 -3.28 12.17 10.85
% of Revenue 51.66 51.95 52.79 53.61 52.57 51.48 51.88 52.25 51.91 51.60 51.55 51.50 52.86 54.02 53.48 52.94 52.78 52.61 56.81 60.71
SG&A 15 15 15 14 14 14 15 15 17 19 19 20 19 19 20 21 22 23 26 29
Change (%) -0.52 -1.33 -1.35 0.35 0.35 2.24 2.20 13.10 11.58 1.50 1.48 -2.14 -2.19 6.16 5.80 4.89 4.67 12.78 11.33
% of Revenue 42.50 42.43 41.31 40.22 41.10 42.00 40.51 39.18 42.97 46.53 46.16 45.81 41.35 37.54 39.80 42.06 45.42 48.99 53.19 57.09
R&D 4 3 4 4 5 5 4 4 5 6 6 5 6 6 6 6 4 2 2 1
Change (%) -4.90 12.97 11.48 6.06 5.72 -8.78 -9.63 20.48 17.00 -2.24 -2.29 3.71 3.58 -1.06 -1.07 -29.14 -41.12 -26.34 -35.75
% of Revenue 10.49 10.01 11.16 12.28 13.26 14.27 12.28 10.51 12.27 13.93 13.31 12.72 12.17 11.70 11.56 11.42 8.34 5.06 3.59 2.22
OpEx 35 34 34 35 35 35 36 38 42 46 46 46 47 48 49 51 49 48 49 50
Change (%) -2.21 1.25 1.23 0.33 0.33 3.72 3.59 11.03 9.93 0.03 0.03 2.09 2.04 2.79 2.71 -2.65 -2.72 2.59 2.52
% of Revenue 99.32 97.50 97.41 97.32 99.41 101.58 99.40 97.44 104.90 111.91 109.42 107.03 100.80 95.47 98.00 100.54 100.76 101.01 99.76 98.60
Operating Income 0 1 1 1 0 -1 0 1 -2 -5 -4 -3 -0 2 1 -0 -0 -0 0 1
Change (%) 268.29 4.94 4.70 -78.47 -364.56 -140.55 346.61 -297.52 150.63 -19.11 -23.62 -87.64 -709.38 -55.92 -126.85 38.66 27.88 -124.84 502.53
% of Revenue 0.68 2.50 2.59 2.68 0.59 -1.58 0.60 2.56 -4.90 -11.91 -9.42 -7.03 -0.80 4.53 2.00 -0.54 -0.76 -1.01 0.24 1.40
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Change (%) 3.23 -13.17 -15.17 -3.94 -4.10 15.95 13.76 20.82 17.23 7.39 6.89 9.20 8.43 -2.14 -2.18 8.93 8.20 23.77 19.20
% of Revenue -1.24 -1.29 -1.10 -0.92 -0.90 -0.88 -0.96 -1.04 -1.22 -1.38 -1.45 -1.52 -1.53 -1.54 -1.51 -1.47 -1.65 -1.84 -2.19 -2.52
Net Income -5 -5 -2 1 0 -0 1 1 -2 -6 -6 -6 -2 1 0 -0 -1 -2 -1 -1
Change (%) -10.98 -60.66 -154.17 -51.55 -106.41 -2,238.71 104.68 -276.34 156.71 -0.17 -0.17 -60.06 -150.39 -63.72 -175.62 185.65 64.99 -10.08 -11.20
% of Revenue -15.06 -13.45 -5.22 2.79 1.38 -0.09 1.81 3.51 -6.01 -14.97 -14.61 -14.26 -5.25 2.46 0.89 -0.67 -1.98 -3.36 -2.91 -2.49

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista